Abcellera Biologics Inc • ABCL

Capital at risk.

About Abcellera Biologics Inc
Ticker
info
ABCL
Trading on
info
NASDAQ
ISIN
info
CA00288U1066
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Carl L.G. Hansen Ph.D.
Headquarters
info
150 West 4th Ave, Vancouver, BC, Canada, V5Y 1G6
Employees
info
596
Website
info
abcellera.com
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Metrics
BasicAdvanced
Market cap
info
$1.04B
P/E ratio
info
-
EPS
info
-$0.56
Dividend Yield
info
0.00%
Beta
info
0.36
Forward P/E ratio
info
27.47
EBIDTA
info
$-231M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.04B
Average daily volume
info
6.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
27.47
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
44.81
Price to book
info
1.01
Earnings
EPS
info
-$0.56
EPS estimate (current quarter)
info
-$0.14
EPS estimate (next quarter)
info
-$0.15
EBITDA
info
$-231M
Revenues (TTM)
info
$23.1M
Revenues per share (TTM)
info
$0.08
Technicals
Beta
info
0.36
52-week High
info
$3.68
52-week Low
info
$1.89
50-day moving average
info
$2.38
200-day moving average
info
$2.67
Short ratio
info
5.74
Short %
info
9.93%
Management effectiveness
ROE (TTM)
info
-15.60%
ROA (TTM)
info
-12.94%
Profit margin
info
0.00%
Gross profit margin
info
$-147M
Operating margin
info
-1,479.58%
Growth
Quarterly earnings growth (YoY)
info
45.90%
Quarterly revenue growth (YoY)
info
-57.50%
Share stats
Outstanding Shares
info
298M
Float
info
202M
Insiders %
info
22.97%
Institutions %
info
44.69%
Analyst Insights & forecasts
info

89% Buy

11% Hold

0% Sell

Based on information from 9 analysts.

Average price target

info
$8.43
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.13
-$0.14
7.14%
Q2 • 24Beat
-$0.17
-$0.15
-13.33%
Q3 • 24Missed
-$0.12
-$0.15
18.42%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$5.1M
$-34.2M
-677.43%
Q4 • 24
$4.2M
$-45.6M
-1,077.24%
Q1 • 25
-16.14%
33.36%
59.02%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.36B
$304M
22.38%
Q4 • 24
$579M
$246M
42.44%
Q1 • 25
-57.43%
-19.26%
89.65%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-8M
$35.7M
$4.1M
$-23.6M
Q4 • 24
$-11.6M
$7.9M
$6M
$-22.2M
Q1 • 25
44.43%
-77.77%
44.13%
-6.09%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Abcellera Biologics Inc share?
Collapse

Abcellera Biologics Inc shares are currently traded for undefined per share.

How many shares does Abcellera Biologics Inc have?
Collapse

Abcellera Biologics Inc currently has 298M shares.

Does Abcellera Biologics Inc pay dividends?
Collapse

No, Abcellera Biologics Inc doesn't pay dividends.

What is Abcellera Biologics Inc 52 week high?
Collapse

Abcellera Biologics Inc 52 week high is $3.68.

What is Abcellera Biologics Inc 52 week low?
Collapse

Abcellera Biologics Inc 52 week low is $1.89.

What is the 200-day moving average of Abcellera Biologics Inc?
Collapse

Abcellera Biologics Inc 200-day moving average is $2.67.

Who is Abcellera Biologics Inc CEO?
Collapse

The CEO of Abcellera Biologics Inc is Dr. Carl L.G. Hansen Ph.D..

How many employees Abcellera Biologics Inc has?
Collapse

Abcellera Biologics Inc has 596 employees.

What is the market cap of Abcellera Biologics Inc?
Collapse

The market cap of Abcellera Biologics Inc is $1.04B.

What is the P/E of Abcellera Biologics Inc?
Collapse

The current P/E of Abcellera Biologics Inc is null.

What is the EPS of Abcellera Biologics Inc?
Collapse

The EPS of Abcellera Biologics Inc is -$0.56.

What is the PEG Ratio of Abcellera Biologics Inc?
Collapse

The PEG Ratio of Abcellera Biologics Inc is null.

What do analysts say about Abcellera Biologics Inc?
Collapse

According to the analysts Abcellera Biologics Inc is considered a buy.